Cytospire Therapeutics (‘Cytospire’), a UK based biotech developing differentiated multispecific immune cell engager antibodies designed to enhance and direct the activity of the body’s own immune ...

In the first quarter of 2026, Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA margin of 37.8%. Ester Baiget, Pres ...

Ester Baiget, President & CEO:” The year started strong with 7% organic sales growth against a high comparable. We delivered growth across all sales areas and in both Developed and Emerging markets, ...

Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on May 26, 2026, at 10.00am CEST (doors open at 9:30 am CEST) at the ...

Munich, Germany and Riyadh, Saudi Arabia - neurocare group AG (“neurocare” or the “Company”), a best practice platform for mental health and performance, is pleased to announce the Saudi Food & Drug ...

(NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced the ...

Men who land on this page searched something specific to get here. "Elite Pro Force Male Enhancement Gummies scam," "Elite Pro Force complaints," or "Ultra Peak Horse Gelatin Trick for Men" — these ...

For interested individuals unable to join the conference call, a webcast of the call will be available until June 12, 2026 and can be accessed via webcast on Jushi’s Investor Re ...

Dentsply Sirona (Nasdaq: XRAY), the world’s largest diversified manufacturer of professional dental products and technologies, today announced an enhanced distribution agreement with Atlanta Dental ...

How Vital Wrist Monitor's Blood Pressure Tracking and Vital Wrist Ball's Progressive Gyroscopic Resistance Work: At-Home Wrist Health Devices Explained for 2026. Miami, FL, May 04 ...

Providence Saint John’s Health Center is strengthening its commitment to and vision for maternal and newborn care through the naming of the Maria Shriver Labor, Delivery and Family Wellness Unit. This ...

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. “The first quarter reflected continued execution across CRISPR Therapeutics’ platform,” ...